秀強股份(300160.SZ):為特斯拉充電樁用玻璃產品國內唯一供應商 訂單量約一萬片每月
格隆匯2月14日丨秀強股份(300160.SZ)回覆深交所關注函稱,公司為美國特斯拉新能源汽車充電樁用玻璃產品的國內唯一供應商,目前訂單量約一萬片每月。公司於2019年5月開始介入特斯拉太陽能屋頂項目,已經完成初步樣品確認,尚未取得特斯拉太陽能屋頂玻璃的批量訂單。公司正在建設太陽能屋頂玻璃一期生產線,生產線將於2020年5月建設完成,生產線建成後產能為每週100個太陽能屋頂。目前特斯拉正在美國加緊安裝太陽能屋頂,而且該業務將很快進軍中國和歐洲市場,太陽能屋頂玻璃的市場需求將大幅增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.